(Q54308569)

27 May 2018

title

Relationship between the neuroprotective effects of insulin-like growth factor-1 and 17β-oestradiol in human neuroblasts. (English)

1 reference

27 May 2018

author name string

P Luciani

1

1 reference

27 May 2018

C Deledda

2

1 reference

27 May 2018

S Benvenuti

3

1 reference

27 May 2018

I Cellai

4

1 reference

27 May 2018

G Modi

5

1 reference

27 May 2018

B Fibbi

6

1 reference

27 May 2018

G Danza

7

1 reference

27 May 2018

G B Vannelli

8

1 reference

27 May 2018

A Peri

9

1 reference

27 May 2018

publication date

1 October 2012

1 reference

27 May 2018

Journal of Neuroendocrinology

published in

1 reference

27 May 2018

volume

24

1 reference

27 May 2018

issue

10

1 reference

27 May 2018

page(s)

1304-1310

1 reference

27 May 2018

The insulin-like growth factor system and its pleiotropic functions in brain

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

Interdependence of oestrogen and insulin-like growth factor-I in the brain: potential for analysing neuroprotective mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

The molecular mechanism of endoplasmic reticulum stress-induced apoptosis in PC-12 neuronal cells: the protective effect of insulin-like growth factor I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

IGF-1 derived small neuropeptides and analogues: a novel strategy for the development of pharmaceuticals for neurological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: Insights from basic science and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

Actions of estrogens on glial cells: Implications for neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

Interactions of estradiol and insulin-like growth factor-I signalling in the nervous system: new advances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

Regulation of neuronal survival by the serine-threonine protein kinase Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

Insulin-like growth factors activate estrogen receptor to control the growth and differentiation of the human neuroblastoma cell line SK-ER3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

Divergent pathways regulate ligand-independent activation of ER alpha in SK-N-BE neuroblastoma and COS-1 renal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

Growth hormone (GH) and GH-releasing peptide-6 increase brain insulin-like growth factor-I expression and activate intracellular signaling pathways involved in neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

Phosphatidylinositol 3-kinase and glycogen synthase kinase 3 regulate estrogen receptor-mediated transcription in neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

Seladin-1 is a fundamental mediator of the neuroprotective effects of estrogen in human neuroblast long-term cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

Estrogen and selective estrogen receptor modulators exert neuroprotective effects and stimulate the expression of selective Alzheimer's disease indicator-1, a recently discovered antiapoptotic gene, in human neuroblast long-term cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

Mutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

Reduced membrane lipids in the cortex of Alzheimer's disease transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

The role of seladin-1/DHCR24 in cholesterol biosynthesis, APP processing and Abeta generation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

Neuronal membrane cholesterol loss enhances amyloid peptide generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

A lipid boundary separates APP and secretases and limits amyloid beta-peptide generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

Intermittent high glucose concentrations reduce neuronal precursor survival by altering the IGF system: the involvement of the neuroprotective factor DHCR24 (Seladin-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

Sex steroids and odorants modulate gonadotropin-releasing hormone secretion in primary cultures of human olfactory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

Expression and biological effects of endothelin-1 in human gonadotropin-releasing hormone-secreting neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

IGF-I gene variability is associated with an increased risk for AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

Insulin-like growth factor I and Alzheimer's disease: therapeutic prospects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

IGF-1-induced processing of the amyloid precursor protein family is mediated by different signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

An antagonist of estrogen receptors blocks the induction of adult neurogenesis by insulin-like growth factor-I in the dentate gyrus of adult female rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

Insulin-like growth factor-I receptor and estrogen receptor crosstalk mediates hormone-induced neurite outgrowth in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

MAPK signaling is critical to estradiol protection of CA1 neurons in global ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

Rediscovering good old friend IGF-I in the new millenium: possible usefulness in Alzheimer's disease and stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

Use of serum insulin-like growth factor-I levels to predict psychiatric non-response to donepezil in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

The effect of peripheral administration of growth hormone on AD-like cognitive deficiency in NBM-lesioned rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

Grafts and growth factors in CNS. Basic science with clinical promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

Effects of estrogen in the brain: is it a neuroprotective agent in Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02343.X

10.1111/J.1365-2826.2012.02343.X

21 January 2018

Identifiers

DOI

1 reference

27 May 2018

1 reference

27 May 2018